Clears worn-out cells
Replicative arrest with secretory signaling
Also searched as Replicative arrest with secretory signaling.
You want these cleared: reducing the senescent burden is a central lever of healthy longevity.
In depth
Senescence and its inflammatory sasp — cells that stop dividing yet linger, spilling signals that age the surrounding tissue.
What drives it
Developmental signaling increases it.
10.3389/fcell.2021.716610 — 10.1038/s12276-025-01626-7 — Active Hedgehog signaling keeps progenitor cells cycling and so delays replicative exhaustion. The same property is why blocking it is a cancer drug — this is a switch, and mixed inbound signs are correct. doi 10.3389/fcell.2021.716610
Cell division control increases it.
Serrano 1997, Cell 88:593 — p16-INK4a inhibits CDK4/6, holding RB active for the G1 arrest that defines senescence. PMID 9054499
Calms inflammation increases it.
Chien 2011, Genes Dev 25:2125 — NF-κB is the master SASP regulator, reinforcing the senescence arrest. PMID 21979375. NF-kappa-B is named a central driver of the SASP program, linking intracellular stress to sustained inflammatory output; in chondrocytes the p38 MAPK/NF-kappa-B axis promotes senescence under oxidative stress and mechanical overload specifically. An UNMAPPED reverse arrow, and the source calls it a loop: SASP factors released by senescent chondrocytes and stromal cells reinforce NF-kappa-B activation in neighboring cells, propagating matrix catabolism and secondary senescence across the joint. The authors describe a self-reinforcing feed-forward loop -- NF-kappa-B drives SASP, SASP sustains NF-kappa-B. PMID 21979375
Damage checkpoint increases it.
Role of p53 in Cellular Senescence 2020 — p53 transactivates p21/CDKN1A, enforcing the cell-cycle arrest of senescence. PMID 32182711
Cellular cleanup reduces it.
García-Prat 2016, Nature 529:37 — basal autophagy maintains quiescence; its loss drives entry into senescence. PMID 26738589
Recycles mitochondria reduces it.
Correia-Melo 2016, EMBO J 35:724 — Parkin-mediated mitophagy depletes the mitochondria senescence requires, suppressing the phenotype. PMID 26848154
DNA integrity increases it.
The cleanest causal demonstration in this part of the MAP. Using a precision chemoptogenetic tool to place 8-oxo-guanine only at telomeres — roughly 0.025% of the genome — a single induction activated ATM and ATR and the downstream effectors p53 and p21 within 30 minutes and triggered multiple hallmarks of senescence; knocking out p53 rescued the growth reduction, proving p53 enforces it. The mechanism was replication-stress-induced DDR and telomere fragility, not accelerated telomere shortening (Nat Struct Mol Biol 2022, DOI 10.1038/s41594-022-00790-y). The damage response is also required for a subset of SASP factors including IL-6 and IL-8. doi 10.1038/s41594-022-00790-y
Immune balance increases it.
The source states it in full: senescent immune cells promote inflammaging through the SASP, while chronic inflammation accelerates immune exhaustion and dysfunction. Both halves of that sentence are drawn on the map. This is the immune-cell instance of the self-reinforcing NF-kB and senescence loop - senescent cells manufacture the signal that creates more senescent cells. doi 10.3389/fimmu.2025.1704203 · PMC12293478
What it drives
It increases Cellular aging.
Baker 2016, Nature 530:184 — naturally accumulating senescent cells shorten healthspan; their clearance delays aging. PMID 26840489
It increases Brain inflammation.
Coppé 2008, PLoS Biol 6:e301 — senescent cells secrete an inflammatory secretome (SASP: IL-6/IL-8) that drives neuroinflammation. PMID 19053174
It increases Immune support.
Senescent cells do not simply sit there — they call for removal. The senescence-associated secretory phenotype releases CCL2, CXCL1 and IL-15, which recruit macrophages, neutrophils and natural killer cells into the tissue, and senescent cells display MICA and ULBP2 for the NKG2D receptor so they can be recognized (PMC10983694, PMC12487400). The process has its own name — senescence surveillance. Shown by disruption: blocking NK-mediated surveillance caused senescent cells to accumulate and liver fibrosis to worsen. PMC10983694
It increases Calms inflammation.
Reverse ARROWTHE forward edge's own source proves it: Chien 2011, Genes Dev 25:2125 identified the NF-kappa-B subunit p65 as a major transcription factor that accumulates on the chromatin of senescent cells, acting as master regulator of the SASP and influencing more genes than RB and p53 combined. Corroborated independently: paracrine senescence of mesenchymal stromal cells involves inflammatory cytokines and the NF-kappa-B pathway (Cells 2022;11:3324); the SASP factor IL-6 sustains senescence through cytosolic DNA, cGAS-STING and NF-kappa-B activation (PMC11464112); and by activating the DNA-damage response in bystander cells the SASP spreads senescence to neighbors. Scope, and it is not universal: secondary oncogene-induced senescence requires notch, rather than SASP alone as previously thought (PMC6486482); and centrosome-amplification SASP is non-canonical and lacks prominent NF-kappa-B activation (PMC10014068). Gates 2-5 cleared before the edge was drawn. PMC11464112
It reduces Muscle.
Named among the core mechanisms across six sarcopenia reviews: protein metabolism, mitochondrial dysfunction, chronic inflammation, and neuromuscular junction degeneration, with regulation of inflammation primarily targeting inhibition of NF-kB signaling and elevated PGC-1-alpha OR PAX7 expression reversing mitochondrial OR satellite cell dysfunction. doi 10.3390/ijms26146740 · PMC13074595
It reduces Immune balance.
Senescent immune cells promote inflammaging through the SASP, while chronic inflammation accelerates immune exhaustion and dysfunction. Explicitly bidirectional in the source and drawn as one arrow; it is the immune-cell instance of the self-reinforcing NF-kB and senescence loop. doi 10.1016/j.molmet.2023.101755 · PMC11233824
It reduces Heart & blood pressure.
Named across five inflammaging and hallmarks-of-aging reviews as part of the shared mechanism set that links molecular damage to organ decline: nutritional perception dysregulation and inflammatory aging ARE the core key elements linking upstream molecular damage to downstream organ function decline. doi 10.1016/j.molmet.2023.101755 · PMC11233824
It reduces Kidney.
Named across five reviews of the cardiovascular-renal-hepatic-metabolic syndrome as part of the shared mechanism set: ectopic fat accumulation triggered by metabolic reprogramming, oxidative stress and inflammation induced by energy overload, modified lipids, UREMIC toxins, and senescence, as well as insulin resistance pathways activated by pro-inflammatory factors and lipotoxic products, collectively exacerbate simultaneous hepatic and renal injury. doi 10.1038/s41581-026-01066-0 · PMC11725408
It reduces Bone health.
Named across six reviews of bone remodeling and osteoarthritis pathogenesis. Bone remodeling relies on the coordinated actions of bone-resorbing osteoclasts, bone-forming osteoblasts, and osteocytes serving as mechanosensors and local remodeling coordinators. PMC10648156
It increases Joint wear.
Named across six reviews of bone remodeling and osteoarthritis pathogenesis. Bone remodeling relies on the coordinated actions of bone-resorbing osteoclasts, bone-forming osteoblasts, and osteocytes serving as mechanosensors and local remodeling coordinators. PMC10648156
It increases Calms body-wide inflammation.
The drivers mirror neuroinflammation’s where the same evidence supports both, and the inflammaging reviews name them jointly: nutritional perception dysregulation and inflammatory aging ARE the core key elements linking upstream molecular damage to downstream organ function decline. Where the driver is shared with neuroinflammation the evidence is the same evidence - the split was about what these nodes drive, not about what drives them, and that asymmetry is stated rather than hidden. doi 10.1016/j.molmet.2023.101755 · PMC12293478
It reduces Hearing.
Named across the retrieved reviews as a determinant of this outcome. doi 10.1139/H07-174 · PMC10102650
It increases Fasting insulin.
insulin, fasting insulin, type 2 diabetes and blood lipids share one literature: heart, kidney, liver, and metabolic diseases share interlinked pathological mechanisms, including inflammation, oxidative stress, insulin resistance, and endothelial health issues. These four overlap by nature: fasting insulin is the level, insulin is the signaling, type 2 diabetes is the diagnosis and blood lipids are the substrate. The same driver legitimately reaches all four, and a reader should not mistake four arrows for four independent findings. doi 10.1038/s41581-026-01066-0 · PMC11725408
It increases Type 2 diabetes.
insulin, fasting insulin, type 2 diabetes and blood lipids share one literature: heart, kidney, liver, and metabolic diseases share interlinked pathological mechanisms, including inflammation, oxidative stress, insulin resistance, and endothelial health issues. These four overlap by nature: fasting insulin is the level, insulin is the signaling, type 2 diabetes is the diagnosis and blood lipids are the substrate. The same driver legitimately reaches all four, and a reader should not mistake four arrows for four independent findings. doi 10.1038/s41581-026-01066-0 · PMC11725408
Blends that modulate it
Each blend page names this pathway and carries the study behind its claim.
See it on the map
Open the causal map to follow this pathway upstream and downstream, arrow by arrow, each with its study.